| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/25/2006 | CN1723973A Method for preparing reinforcing kidney and reliefing fatigue ginseng sea horse, semen juglandis and oligose powder |
| 01/25/2006 | CN1723934A Traditional Chinese medicine capsule for treating urinary calculus and its prepn. method |
| 01/25/2006 | CN1723927A Traditional Chinese medicine for treating urinary system infection |
| 01/25/2006 | CN1723923A Method for extracting clerodendranthus spicatus |
| 01/25/2006 | CN1723919A Medicine for treating urinary system stone disease, and its prepn. method |
| 01/25/2006 | CN1723910A Injectable azithromycin freeze-dried powder, and its prepn. method |
| 01/25/2006 | CN1723899A Fibranine micro-pills, and its prepn. method |
| 01/25/2006 | CN1238341C 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 01/25/2006 | CN1238039C Medicinal composition for curing urinary system diseases and its preparing method and uses |
| 01/24/2006 | US6989400 Treatment of benign prostatic hyperplasia |
| 01/24/2006 | US6989393 Ccr5 modulators benzimidazoles or benzotriazoles |
| 01/24/2006 | US6989385 Pyrazole compounds useful as protein kinase inhibitors |
| 01/24/2006 | US6989260 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders |
| 01/24/2006 | US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated |
| 01/24/2006 | CA2187525C Quinolone derivative for treatment of urinary incontinence |
| 01/19/2006 | WO2006006740A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014931 Novel promoter |
| 01/19/2006 | US20060014832 Highly pure bases of 3,3-dipheyl propylamine monoesters |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014709 Drug or cosmetic |
| 01/19/2006 | US20060014701 Novel amide derivatives as growth hormone secretagogues |
| 01/19/2006 | US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) |
| 01/19/2006 | US20060014180 Human phosphatase RET31, and variants thereof |
| 01/19/2006 | US20060013897 Compositions for cancer therapy saponins or sapogenins |
| 01/19/2006 | CA2573441A1 Use of botulinum toxin for the preparation of a medicament for the treatment of lithiasis of salivary gland, gall bladder, kidney, or pancreas |
| 01/19/2006 | CA2570396A1 Antibacterial peptides and analogues thereof |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616570A1 Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 01/18/2006 | EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
| 01/18/2006 | EP1615953A2 Agent comprising an albumin-like first polypeptide bound to a second polypeptide |
| 01/18/2006 | EP1615634A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 01/18/2006 | EP1512016B1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP0954308B1 Therapeutic treatment for cardiovascular diseases |
| 01/18/2006 | EP0782630B1 Polycystic kidney disease gene |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1720959A Pharmaceutical composition for treating acute kidney failure |
| 01/18/2006 | CN1720945A Medicine for treating calculus in urinary system |
| 01/18/2006 | CN1720927A Chinese traditional medicine for tonifying liver and kidney |
| 01/18/2006 | CN1720924A Application of montmorillonite in pharmacy |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987129 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc. |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987116 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987098 Health supplement |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/12/2006 | WO2006004115A1 Remedy for hyperactive bladder |
| 01/12/2006 | WO2003089596A3 Novel prostate tumor-specific promoter |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009502 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009436 11 beta -Fluoro-7 alpha -{5-[methyl(7,7,8,8,9,9,9-heptafluorononyl)amino]pentyl}-17 alpha -methylestra-1,3,5(10)-triene-3,17 beta -diol N-oxide; antiestrogen compound whose metabolism can be controlled; alveolar macrophages do not build up; oral administration |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060008804 Marker genes |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1613596A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor |
| 01/11/2006 | EP1613584A1 Highly pure bases of 3,3-diphenyl propylamine monoesters |
| 01/11/2006 | EP1613327A2 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1358169B1 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase |
| 01/11/2006 | EP1353660B1 Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | EP0728209B1 Endothelin-converting enzyme |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |